Tilray Brands is a diversified consumer products company built across four segments: cannabis, craft beverage alcohol, pharmaceutical distribution, and hemp wellness foods. The cannabis segment covers cultivation and sales in Canada for both medical and adult-use recreational markets, plus international medical cannabis sales across Europe, Australia, and Latin America. Canada is the largest market, where Tilray holds roughly 9-10% adult-use share with brands including Redecan, Good Supply, and Broken Coast. Internationally, Tilray sells EU-GMP certified medical cannabis primarily in Germany, Poland, Italy, the UK, and Australia. The craft beverage segment makes Tilray the 4th largest craft brewer in the U.S. by volume, with brands including SweetWater, Montauk, 10 Barrel, and Breckenridge Brewery, distributed through ~500 beer distributors into ~50,000 retail locations. The distribution segment is almost entirely CC Pharma, a German pharmaceutical importer that serves ~13,000 pharmacies across ~1,200 product lines — also a key asset for Tilray's German cannabis distribution. The wellness segment is led by Manitoba Harvest, a hemp food brand with roughly 60% U.S. branded market share. Tilray's growth strategy focuses on European cannabis expansion, leveraging CC Pharma's pharmacy network; building U.S. beverage scale through cost savings and entry into hemp-derived Delta-9 THC beverages; and positioning its U.S. distribution infrastructure as a platform for eventual U.S. cannabis legalization.
Read full business overview →Mid to long-term bullish thesis
View →Mid to long-term bearish thesis
View →Mid to long-term bull-bear debate
View → NEWSummary and scoring of the bull-bear debate
View →Find ideas with similar bull or bear theses
View →Investor-relevant company attributes
View →Key risks to the business
View →Comparisons of annual risk disclosures
View →